ip 66 has been researched along with quinazolines in 1 studies
| Studies (ip 66) | Trials (ip 66) | Recent Studies (post-2010) (ip 66) | Studies (quinazolines) | Trials (quinazolines) | Recent Studies (post-2010) (quinazolines) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 19,235 | 2,417 | 8,835 |
| Protein | Taxonomy | ip 66 (IC50) | quinazolines (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.027 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castellucci, A | 1 |
1 other study(ies) available for ip 66 and quinazolines
| Article | Year |
|---|---|
Effects of 1-[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxyphenyl)piperazine (IP-66), prazosin, yohimbine and dihydroergotoxine mesylate on the vasoconstriction of rat mesenteric artery induced by electric stimulation and exogenous norepinephrine.
Topics: Animals; Dihydroergotoxine; Electric Stimulation; In Vitro Techniques; Male; Mesenteric Arteries; Norepinephrine; Piperazines; Prazosin; Propranolol; Quinazolines; Rats; Rats, Inbred Strains; Vasoconstriction; Vasoconstrictor Agents; Yohimbine | 1985 |